EUVIMEDEUVIMED entdecken
Open Access

Gut microbiome and antibiotic resistance effects during travelers’ diarrhea treatment and prevention

Kevin S Blake iD, Drew J Schwartz iD, Srinand Paruthiyil iD, Bin Wang, Jie Ning, Sandra D Isidean, Daniel S Burns, Harris Whiteson, Tahaniyat Lalani, Jamie A Fraser, Patrick Connor, Tom Troth und 6 weitere

mBio · 16.01.2024 · 15 (1)

DOI: 10.1128/mbio.02790-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, erschienen am 16.01.2024. Verfasst von Kevin S Blake und 17 weiteren Autor:innen. Beteiligte Einrichtung: The Edison Family Center for Genome Sciences & Systems Biology, Washington University School of Medicine, St. Louis, Missouri, USA. Hauptthemen laut MEDLINE: Diarrhea, Gastrointestinal Microbiome. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, Doris Duke Charitable Foundation, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

International travelers are frequently afflicted by acute infectious diarrhea, commonly referred to as travelers’ diarrhea (TD). Antibiotics are often prescribed as treatment or prophylaxis for TD; however, little is known about the impacts of these regimens on travelers’ gut microbiomes and carriage of antibiotic resistance genes (ARGs). Here, we analyzed two cohorts totaling 153 US and UK servicemembers deployed to Honduras or Kenya. These subjects either experienced TD during deployment and received a single dose of one of three antibiotics [Trial Evaluating Ambulatory Therapy of Travelers’ Diarrhea (TrEAT TD) cohort] or took once-daily rifaximin (RIF), twice-daily RIF, or placebo as prophylaxis to prevent TD [Trial Evaluating Chemoprophylaxis Against Travelers’ Diarrhea (PREVENT TD) cohort]. We applied metagenomic sequencing on 340 longitudinally collected stool samples and whole-genome sequencing on 54 Escherichia coli isolates. We found that gut microbiome taxonomic diversity remained stable across the length of study for most treatment groups, but twice-daily RIF prophylaxis significantly decreased microbiome richness post-travel. Similarly, ARG diversity and abundance were generally stable, with the exception of a significant increase for the twice-daily RIF prophylaxis group. We also did not identify significant differences between the ARG abundance of E. coli isolates from the TrEAT TD cohort collected from different treatment groups or timepoints. Overall, we found no significant worsening of gut microbiome diversity or an increase in ARG abundance following single-dose treatment for TD, underscoring that these can be effective with low risk of impact on the microbiome and resistome, and identified the relative microbiome risks and benefits associated with the three regimens for preventing TD. IMPORTANCE The travelers’ gut microbiome is potentially assaulted by acute and chronic perturbations (e.g., diarrhea, antibiotic use, and different environments). Prior studies of the impact of travel and travelers’ diarrhea (TD) on the microbiome have not directly compared antibiotic regimens, and studies of different antibiotic regimens have not considered travelers’ microbiomes. This gap is important to be addressed as the use of antibiotics to treat or prevent TD—even in moderate to severe cases or in regions with high infectious disease burden—is controversial based on the concerns for unintended consequences to the gut microbiome and antimicrobial resistance (AMR) emergence. Our study addresses this by evaluating the impact of defined antibiotic regimens (single-dose treatment or daily prophylaxis) on the gut microbiome and resistomes of deployed servicemembers, using samples collected during clinical trials. Our findings indicate that the antibiotic treatment regimens that were studied generally do not lead to adverse effects on the gut microbiome and resistome and identify the relative risks associated with prophylaxis. These results can be used to inform therapeutic guidelines for the prevention and treatment of TD and make progress toward using microbiome information in personalized medical care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DiarrheaGastrointestinal MicrobiomeHumansTravelAnti-Bacterial AgentsDrug Resistance, Microbial

Stichwörter der Autor:innen

antibiotic resistancehuman microbiomeinternational traveltravelers' diarrhea

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • The Edison Family Center for Genome Sciences & Systems Biology, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Department of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Center for Women's Infectious Diseases, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Department of Pathology and Immunology, Division of Laboratory and Genomic Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.

ORCID-Profile: Kevin S Blake, Drew J Schwartz, Srinand Paruthiyil, Mark P Simons, Gautam Dantas

Förderung

  • NIDDK NIH HHS
  • Doris Duke Charitable Foundation
  • NIGMS NIH HHS
  • NIAID NIH HHS
  • DOD | USA | MEDCOM | Congressionally Directed Medical Research Programs
  • DOD | Uniformed Services University of the Health Sciences
  • HHS | NIH | National Institute of Allergy and Infectious Diseases
  • HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Blake, K. S., Schwartz, D. J., Paruthiyil, S., Wang, B., Ning, J., Isidean, S. D., Burns, D. S., Whiteson, H., Lalani, T., Fraser, J. A., Connor, P., Troth, T., Porter, C. K., Tribble, D. R., Riddle, M. S., Gutiérrez, R. L., Simons, M. P., & Dantas, G. (2024). Gut microbiome and antibiotic resistance effects during travelers’ diarrhea treatment and prevention. mBio, 15(1). https://doi.org/10.1128/mbio.02790-23

Vancouver

Blake KS, Schwartz DJ, Paruthiyil S, Wang B, Ning J, Isidean SD, et al. Gut microbiome and antibiotic resistance effects during travelers’ diarrhea treatment and prevention. mBio. 2024;15(1). doi:10.1128/mbio.02790-23

BibTeX
@article{Blake2024,
  author = {Blake, Kevin S and Schwartz, Drew J and Paruthiyil, Srinand and Wang, Bin and Ning, Jie and Isidean, Sandra D and Burns, Daniel S and Whiteson, Harris and Lalani, Tahaniyat and Fraser, Jamie A and Connor, Patrick and Troth, Tom and Porter, Chad K and Tribble, David R and Riddle, Mark S and Gutiérrez, Ramiro L and Simons, Mark P and Dantas, Gautam},
  title = {Gut microbiome and antibiotic resistance effects during travelers’ diarrhea treatment and prevention},
  journal = {mBio},
  year = {2024},
  volume = {15},
  number = {1},
  doi = {10.1128/mbio.02790-23}
}
Kostenlos starten →